Department of Clinical Rehabilitation, University of Physical Education, Kraków, Poland; Department of Cardiology and Cardiovascular Interventions, University Hospital, Kraków, Poland.
Collegium Medicum, Jan Kochanowski University, Kielce, Poland
Pol Arch Intern Med. 2020 Aug 27;130(7-8):570-581. doi: 10.20452/pamw.15398. Epub 2020 May 28.
It has been suggested that the time of admission during the day and night may influence the clinical outcomes of patients with acute myocardial infarction (AMI) treated with percutaneous coronary intervention (PCI).
The aim of this study was to assess the impact of day- and night‑time admissions on the clinical outcomes of patients with AMI undergoing PCI.
This retrospective cohort study was based on the data on PCIs performed in Poland from January 2014 to December 2017, prospectively collected in the National Registry of Invasive Cardiology Procedures (ORPKI). Day hours were defined as the time interval between 7:00 am and 10:59 pm. The study endpoints included the all‑cause in‑hospital mortality rate and major adverse cardiovascular and cerebrovascular events (MACCEs) at 30‑day,12‑month, and 36‑month follow‑up.
A total of 2919 patients were included in the study (2462 [84.3%] treated during the day hours). ST‑segment elevation myocardial infarction (1993 [68.3%]) was the main indication for PCI. We demonstrated that the 30‑day mortality rate was significantly higher in patients treated during the night hours than during the day hours (P = 0.01). Night hours were also among the independent predictors of increased 30‑day mortality (hazard ratio, 1.54; 95% CI, 1.11-2.16; P = 0.01). No significant differences were observed in in‑hospital, 12‑month, and 36‑month mortality rates between patients treated during the night and day hours. There were no significant differences in the MACCE rates at the follow‑up timepoints.
Primary PCI for AMI is associated with increased 30‑day mortality among patients treated during the night hours compared with those managed during the day hours.
有人认为,白天和夜间的入院时间可能会影响接受经皮冠状动脉介入治疗(PCI)的急性心肌梗死(AMI)患者的临床结局。
本研究旨在评估 AMI 患者行 PCI 时白天和夜间入院对临床结局的影响。
本回顾性队列研究基于 2014 年 1 月至 2017 年 12 月期间在波兰进行的 PCI 数据,这些数据是在全国介入心脏病学程序登记处(ORPKI)前瞻性收集的。白天时段定义为上午 7:00 至晚上 10:59 之间的时间间隔。研究终点包括全因住院死亡率和 30 天、12 个月和 36 个月随访时的主要不良心血管和脑血管事件(MACCE)。
共纳入 2919 例患者(2462 例[84.3%]在白天时段治疗)。ST 段抬高型心肌梗死(1993 例[68.3%])是 PCI 的主要适应证。我们发现,夜间时段治疗的患者 30 天死亡率显著高于白天时段(P=0.01)。夜间时段也是 30 天死亡风险增加的独立预测因素(风险比,1.54;95%CI,1.11-2.16;P=0.01)。夜间和白天时段治疗的患者在住院期间、12 个月和 36 个月的死亡率无显著差异。在随访时间点,MACCE 发生率无显著差异。
与白天时段相比,夜间时段行 AMI 患者的直接 PCI 治疗与 30 天死亡率增加相关。